Also known as: Mounjaro, Zepbound
FDA-approved dual GLP-1R/GIPR agonist for type 2 diabetes and obesity. Available as Mounjaro and Zepbound.
📖 Read the full Tirzepatide research overview →
Evidence Tier: Tier 1 — Approved Drug · Peptidings Verdict: Strong Foundation